Clinical Trial Update: A Study of GM-XANTHO in Pressure Ulcer Patients [Phase 2]

View source ↗

Summary

Phase 2 clinical trial of GM-XANTHO in patients with pressure ulcers and diabetes mellitus is currently NOT_YET_RECRUITING.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus
• Pressure Ulcer

Drugs mentioned

• GM-XANTHO

Snippet

Sponsor: Xantho Biotechnology Co., LTD | Conditions: Pressure Ulcer, Diabetes Mellitus | Phase 2 | Status: NOT_YET_RECRUITING